ArticleAntimicrobial resistance and infection control2017

Cost-effectiveness of ceftolozane/tazobactam plus metronidazole versus piperacillin/tazobactam as initial empiric therapy for the treatment of complicated intra-abdominal infections based on pathogen distributions drawn from national surveillance data in the United States.

Vimalanand S Prabhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.